Hoersholm Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT00338897
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Hoersholm Hospital (Denmark) | Hoersholm Hospital, Spine Clinic, Usserod Kongevej 102, DK-2970 Hoerholm, Denmark

Active Ingredients

Drugs in Phase 3 Trials (1)

sr 123781a (1 trial)

Drugs in Phase 2 Trials (2)

enoxaparin (lovenox) (1 trial)

semuloparin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thromboembolism (Phase 3)

Venous Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3